Literature DB >> 4842961

Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment.

S R Westenfelder, G Welling, P O Madsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4842961     DOI： 10.1007/bf01642025

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  14 in total

1.  Trimethoprim-sulfamethoxazole: pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans.

Authors:  W A Craig; C M Kunin
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

2.  Serum protein binding of the aminoglycoside antibiotics.

Authors:  R C Gordon; C Regamey; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

3.  Preclinical assessment of the antibacterial activity of nebramycin factor 6.

Authors:  D A Preston; W E Wick
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

4.  Nebramycin, a new broad-spectrum antibiotic complex. IV. In vitro and in vivo laboratory evaluation.

Authors:  W E Wick; J S Welles
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

5.  Rapid microassay for circulating nephrotoxic antibiotics.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  In vitro susceptibility testing with tobramycin.

Authors:  S Shadomy; C Kirchoff
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

7.  In vitro evaluation of tobramycin, a new aminoglycoside antibiotic.

Authors:  M E Levison; R Knight; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

8.  Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate.

Authors:  W H Traub; E A Raymond
Journal:  Appl Microbiol       Date:  1972-01

9.  Tobramycin and gentamicin concentrations in the serum of normal and anephric patients.

Authors:  W R Lockwood; J D Bower
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

10.  Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.

Authors:  C C Crowe; E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191
View more
  6 in total

Review 1.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

2.  Complicated urinary tract infection in adults.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

3.  Therapy of Pseudomonas aeruginosa infections with tobramycin.

Authors:  D C Blair; F R Fekety; B Bruce; J Silva; G Archer
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

Review 4.  Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

5.  [Tobramycin Concentration in Human Lung Tissue (author's transl)].

Authors:  U Kroening; S Liebig; M Wundschock
Journal:  Infection       Date:  1978       Impact factor: 3.553

6.  Netilmicin treatment of complicated urinary tract infection in patients with renal function impairment.

Authors:  N Frimodt-Möller; S Maigaard; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.